Clinical Trials · NCT02152228
A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Entera Bio Ltd.
- Enrollment
- 20
- Start date
- Jul 2014
- Locations
- 1 site, Israel
- Primary endpoint
- Number of participants with adverse events